SCHEMBL8370102

SCHEMBL8370102

Cc1csc([C@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
TSHR P16473 2/20 0.48
CYP3A4 P08684 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MARS2 Q96GW9 1/20 0.45
CYP2C19 P33261 1/20 0.45
RPLP1 P05386 1/20 0.41
RPLP0 P05388 1/20 0.41
RPS17 P08708 1/20 0.41
RPSA P08865 1/20 0.41
RPS2 P15880 1/20 0.41
RPL35A P18077 1/20 0.41
RPL7 P18124 1/20 0.41
RPL17 P18621 1/20 0.41
RPS4Y1 P22090 1/20 0.41
RPS3 P23396 1/20 0.41
RPS12 P25398 1/20 0.41
RPL13 P26373 1/20 0.41
RPL10 P27635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8896392 1.00 LMNA (0.48) LMNATSHRCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL8954422 0.88 DAO (0.39) LMNATSHRCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL8370027 0.87 LMNA (0.35) LMNATSHRCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL9151978 0.87 LMNA (0.35) LMNATSHRCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL8367398 0.80 HTT (0.40) LMNASMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL10757032 0.77 LMNA (0.45) LMNA
SCHEMBL1753533 0.75 LMNA (0.70) LMNATSHRCYP3A4SMN1; SMN2ALDH1A1
SCHEMBL10757714 0.72 ALDH1A1 (0.34) LMNATSHRCYP3A4ALDH1A1CYP2C19
SCHEMBL8589514 0.71 TACR1 (0.34) DAO
SCHEMBL8589511 0.71 TACR1 (0.34) DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0500177-B1 Process for the preparation of trans-(5R)-2,4,5-trisubstituted 2-oxazolines ZAMBON SPA (IT) 1999-01-07 EP disclosed
EP-0500177-A1 Process for the preparation of trans-(5R)-2,4,5-trisubstituted 2-oxazolines ZAMBON GROUP S.p.A. (IT) 1992-08-26 EP disclosed